Irhythm Tech Stock Price, News & Analysis (NASDAQ:IRTC)

$54.00 2.24 (4.33 %)
(As of 11/17/2017 08:00 AM ET)
Previous Close$51.76
Today's Range$51.28 - $54.01
52-Week Range$24.25 - $54.01
Volume315,773 shs
Average Volume266,237 shs
Market Capitalization$1.19 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Irhythm Tech (NASDAQ:IRTC)

Irhythm Tech logoiRhythm Technologies, Inc. is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its algorithms analyze the amounts of captured heart beat data and a concise report is provided to the patient's physician. Its ZIO Report produces a higher diagnostic yield and to change patient management.


Industry, Sector and Symbol:
  • Industry: Medical Monitoring Systems
  • Sub-Industry: N/A
  • Sector: Medical Monitoring Systems
  • Symbol: NASDAQ:IRTC
  • CUSIP: N/A
  • Web: www.irhythmtech.com
Debt:
  • Debt-to-Equity Ratio: 0.36%
  • Current Ratio: 8.15%
  • Quick Ratio: 8.07%
Sales & Book Value:
  • Annual Sales: $64.07 million
  • Price / Sales: 19.37
  • Book Value: $4.18 per share
  • Price / Book: 12.92
Profitability:
  • Trailing EPS: ($1.19)
  • Net Income: ($20,900,000.00)
  • Net Margins: -27.56%
  • Return on Equity: -27.33%
  • Return on Assets: -18.16%
Misc:
  • Employees: 406
  • Outstanding Shares: 22,980,000
 

Frequently Asked Questions for Irhythm Tech (NASDAQ:IRTC)

What is Irhythm Tech's stock symbol?

Irhythm Tech trades on the NASDAQ under the ticker symbol "IRTC."

How were Irhythm Tech's earnings last quarter?

Irhythm Tech (NASDAQ:IRTC) issued its earnings results on Wednesday, November, 1st. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.34) by $0.05. The business earned $25.04 million during the quarter, compared to the consensus estimate of $24.30 million. Irhythm Tech had a negative return on equity of 27.33% and a negative net margin of 27.56%. The company's revenue for the quarter was up 49.2% on a year-over-year basis. During the same period last year, the company earned ($2.80) EPS. View Irhythm Tech's Earnings History.

When will Irhythm Tech make its next earnings announcement?

Irhythm Tech is scheduled to release their next quarterly earnings announcement on Wednesday, February, 21st 2018. View Earnings Estimates for Irhythm Tech.

Where is Irhythm Tech's stock going? Where will Irhythm Tech's stock price be in 2017?

3 Wall Street analysts have issued 12 month price targets for Irhythm Tech's stock. Their predictions range from $59.00 to $65.00. On average, they anticipate Irhythm Tech's share price to reach $62.00 in the next year. View Analyst Ratings for Irhythm Tech.

What are Wall Street analysts saying about Irhythm Tech stock?

Here are some recent quotes from research analysts about Irhythm Tech stock:

  • 1. Canaccord Genuity analysts commented, "We expect these data, assuming the read-out of the full study data follows suit (which we expect), will build IRTC’s case with payers, paving the way ultimately for prospective screening with Zio in a brand new, 3- million-patient TAM. While not in our model at all, we think over time, payors will cover Zio for screening of high-risk patients defined by the mSToPs study. We reiterate our BUY rating and $59 price target." (11/14/2017)
  • 2. According to Zacks Investment Research, "iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. " (10/11/2017)

Who are some of Irhythm Tech's key competitors?

Who are Irhythm Tech's key executives?

Irhythm Tech's management team includes the folowing people:

  • Abhijit Y. Talwalkar, Independent Chairman of the Board (Age 53)
  • Kevin M. King, President, Chief Executive Officer, Director (Age 60)
  • Matthew C. Garrett, Chief Financial Officer (Age 49)
  • David A. Vort, Executive Vice President of Sales (Age 51)
  • Derrick Sung Ph.D., Executive Vice President - Strategy and Corporate Development (Age 44)
  • Bruce G. Bodaken, Director (Age 65)
  • Ralph Snyderman M.D., Director (Age 77)
  • Vijay K. Lathi, Independent Director (Age 43)
  • Mark Jeffrey Rubash, Independent Director (Age 60)
  • Raymond W. Scott, Independent Director (Age 70)

When did Irhythm Tech IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who owns Irhythm Tech stock?

Irhythm Tech's stock is owned by many different of institutional and retail investors. Top institutional shareholders include TimesSquare Capital Management LLC (3.50%), Bank of New York Mellon Corp (3.24%), Wells Fargo & Company MN (2.68%), Perceptive Advisors LLC (1.64%), Citadel Advisors LLC (1.42%) and JPMorgan Chase & Co. (1.38%). Company insiders that own Irhythm Tech stock include David A Vort, Kevin M King, Matthew C Garrett, Raymond W Scott, Synergy Life Science Partners and Vijay K Lathi. View Institutional Ownership Trends for Irhythm Tech.

Who sold Irhythm Tech stock? Who is selling Irhythm Tech stock?

Irhythm Tech's stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., TimesSquare Capital Management LLC, Citadel Advisors LLC, Columbus Circle Investors, Neuberger Berman Group LLC, Pier Capital LLC, Mackenzie Financial Corp and Victory Capital Management Inc.. Company insiders that have sold Irhythm Tech company stock in the last year include David A Vort, Kevin M King, Matthew C Garrett, Raymond W Scott, Synergy Life Science Partners and Vijay K Lathi. View Insider Buying and Selling for Irhythm Tech.

Who bought Irhythm Tech stock? Who is buying Irhythm Tech stock?

Irhythm Tech's stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Wells Fargo & Company MN, Bank of New York Mellon Corp, Barometer Capital Management Inc., Ameriprise Financial Inc., Perceptive Advisors LLC, EAM Investors LLC and Strs Ohio. View Insider Buying and Selling for Irhythm Tech.

How do I buy Irhythm Tech stock?

Shares of Irhythm Tech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Irhythm Tech's stock price today?

One share of Irhythm Tech stock can currently be purchased for approximately $54.00.

How big of a company is Irhythm Tech?

Irhythm Tech has a market capitalization of $1.19 billion and generates $64.07 million in revenue each year. The company earns ($20,900,000.00) in net income (profit) each year or ($1.19) on an earnings per share basis. Irhythm Tech employs 406 workers across the globe.

How can I contact Irhythm Tech?

Irhythm Tech's mailing address is 650 Townsend St Ste 380, SAN FRANCISCO, CA 94103-6248, United States. The company can be reached via phone at +1-415-6325700 or via email at [email protected]


MarketBeat Community Rating for Irhythm Tech (NASDAQ IRTC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  66 (Vote Underperform)
Total Votes:  135
MarketBeat's community ratings are surveys of what our community members think about Irhythm Tech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Irhythm Tech (NASDAQ:IRTC)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $62.00 (14.81% upside)

Consensus Price Target History for Irhythm Tech (NASDAQ:IRTC)

Price Target History for Irhythm Tech (NASDAQ:IRTC)

Analysts' Ratings History for Irhythm Tech (NASDAQ:IRTC)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/14/2017Canaccord GenuityReiterated RatingBuy$59.00N/AView Rating Details
11/3/2017Morgan StanleyBoost Price TargetOverweight$50.00 -> $65.00N/AView Rating Details
12/6/2016BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
11/14/2016J P Morgan Chase & CoInitiated CoverageOverweight$34.00N/AView Rating Details
(Data available from 11/18/2015 forward)

Earnings

Earnings History and Estimates Chart for Irhythm Tech (NASDAQ:IRTC)

Earnings by Quarter for Irhythm Tech (NASDAQ:IRTC)

Earnings History by Quarter for Irhythm Tech (NASDAQ IRTC)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/21/2018        
11/1/2017Q3 2017($0.34)($0.29)$24.30 million$25.04 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.31)($0.29)$22.10 million$23.85 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.36)($0.24)$19.13 million$21.40 millionViewListenView Earnings Details
2/15/2017Q416($0.28)($0.37)$17.33 million$18.70 millionViewListenView Earnings Details
12/5/2016Q3 2016($0.27)($2.80)$16.52 million$16.80 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Irhythm Tech (NASDAQ:IRTC)
Current Year EPS Consensus Estimate: $-1.16 EPS
Next Year EPS Consensus Estimate: $-0.91 EPS

Dividends

Dividend History for Irhythm Tech (NASDAQ:IRTC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Irhythm Tech (NASDAQ IRTC)

Insider Ownership Percentage: 23.30%
Institutional Ownership Percentage: 95.22%
Insider Trades by Quarter for Irhythm Tech (NASDAQ:IRTC)
Institutional Ownership by Quarter for Irhythm Tech (NASDAQ:IRTC)

Insider Trades by Quarter for Irhythm Tech (NASDAQ IRTC)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/6/2017Kevin M KingInsiderSell60,000$51.85$3,111,000.00View SEC Filing  
9/13/2017Vijay K LathiDirectorSell34,613$49.51$1,713,689.63View SEC Filing  
9/12/2017David A. VortEVPSell5,000$48.76$243,800.00View SEC Filing  
9/7/2017Raymond W ScottDirectorSell8,088$48.00$388,224.00View SEC Filing  
9/6/2017Raymond W ScottDirectorSell4,661$48.02$223,821.22View SEC Filing  
8/28/2017Raymond W ScottDirectorSell12,749$45.30$577,529.70View SEC Filing  
8/7/2017Raymond W. ScottDirectorSell52,903$43.59$2,306,041.77View SEC Filing  
7/11/2017Kevin M. KingInsiderSell110,000$42.08$4,628,800.00View SEC Filing  
7/10/2017Matthew C. GarrettCFOSell25,086$42.06$1,055,117.16View SEC Filing  
6/8/2017Synergy Life Science PartnersMajor ShareholderSell350,000$37.43$13,100,500.00View SEC Filing  
6/8/2017Vijay K LathiDirectorSell430,624$37.59$16,187,156.16View SEC Filing  
5/16/2017Vijay K LathiDirectorSell645,000$34.70$22,381,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Irhythm Tech (NASDAQ:IRTC)

Latest Headlines for Irhythm Tech (NASDAQ IRTC)

Source:
DateHeadline
Canaccord Genuity Reiterates Buy Rating for Irhythm Tech (IRTC)Canaccord Genuity Reiterates Buy Rating for Irhythm Tech (IRTC)
www.americanbankingnews.com - November 14 at 11:03 PM
iRhythm Technologies, Inc. breached its 50 day moving average in a Bearish Manner : IRTC-US : November 9, 2017iRhythm Technologies, Inc. breached its 50 day moving average in a Bearish Manner : IRTC-US : November 9, 2017
finance.yahoo.com - November 11 at 1:28 PM
iRhythm Technologies, Inc. – Value Analysis (NASDAQ:IRTC) : November 10, 2017iRhythm Technologies, Inc. – Value Analysis (NASDAQ:IRTC) : November 10, 2017
finance.yahoo.com - November 11 at 1:28 PM
Irhythm Tech (IRTC) Insider Sells $3,111,000.00 in StockIrhythm Tech (IRTC) Insider Sells $3,111,000.00 in Stock
www.americanbankingnews.com - November 8 at 12:40 PM
ETFs with exposure to iRhythm Technologies, Inc. : November 6, 2017ETFs with exposure to iRhythm Technologies, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 4:55 AM
IRHYTHM TECH (IRTC) Price Target Raised to $65.00 at Morgan StanleyIRHYTHM TECH (IRTC) Price Target Raised to $65.00 at Morgan Stanley
www.americanbankingnews.com - November 5 at 10:18 AM
Irhythm Tech (IRTC) PT Raised to $59.00 at Canaccord GenuityIrhythm Tech (IRTC) PT Raised to $59.00 at Canaccord Genuity
www.americanbankingnews.com - November 2 at 9:48 PM
iRhythm Technologies, Inc. to Host Earnings CalliRhythm Technologies, Inc. to Host Earnings Call
finance.yahoo.com - November 2 at 2:47 AM
iRhythm Technologies Announces Third Quarter 2017 Financial Results and Raises Guidance for Full Year 2017iRhythm Technologies Announces Third Quarter 2017 Financial Results and Raises Guidance for Full Year 2017
finance.yahoo.com - November 2 at 2:47 AM
Irhythm Tech (IRTC) Posts  Earnings Results, Beats Expectations By $0.05 EPSIrhythm Tech (IRTC) Posts Earnings Results, Beats Expectations By $0.05 EPS
www.americanbankingnews.com - November 1 at 6:38 PM
ETFs with exposure to iRhythm Technologies, Inc. : October 27, 2017ETFs with exposure to iRhythm Technologies, Inc. : October 27, 2017
finance.yahoo.com - October 28 at 7:10 AM
Irhythm Tech (IRTC) to Release Earnings on WednesdayIrhythm Tech (IRTC) to Release Earnings on Wednesday
www.americanbankingnews.com - October 25 at 10:30 AM
IRHYTHM TECH (IRTC) Rating Increased to Hold at ValuEngineIRHYTHM TECH (IRTC) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - October 21 at 10:40 AM
Irhythm Tech (IRTC) Given Consensus Rating of "Buy" by BrokeragesIrhythm Tech (IRTC) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - October 21 at 3:04 AM
iRhythm Technologies to Report Third Quarter 2017 Financial Results on November 1, 2017iRhythm Technologies to Report Third Quarter 2017 Financial Results on November 1, 2017
finance.yahoo.com - October 18 at 4:48 PM
ETFs with exposure to iRhythm Technologies, Inc. : October 17, 2017ETFs with exposure to iRhythm Technologies, Inc. : October 17, 2017
finance.yahoo.com - October 18 at 2:29 AM
Say Goodbye To Your Smartphone: The Wearables Future Has ArrivedSay Goodbye To Your Smartphone: The Wearables Future Has Arrived
seekingalpha.com - October 17 at 12:32 AM
Brokerages Anticipate Irhythm Tech (IRTC) to Post ($0.34) Earnings Per ShareBrokerages Anticipate Irhythm Tech (IRTC) to Post ($0.34) Earnings Per Share
www.americanbankingnews.com - October 13 at 6:44 AM
ETFs with exposure to iRhythm Technologies, Inc. : October 6, 2017ETFs with exposure to iRhythm Technologies, Inc. : October 6, 2017
finance.yahoo.com - October 6 at 11:55 PM
iRhythm Technologies, Inc. :IRTC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017iRhythm Technologies, Inc. :IRTC-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017
finance.yahoo.com - October 6 at 1:11 AM
Irhythm Tech (IRTC) Price Target Raised to $55.00 at Canaccord GenuityIrhythm Tech (IRTC) Price Target Raised to $55.00 at Canaccord Genuity
www.americanbankingnews.com - September 22 at 8:47 AM
Irhythm Tech (IRTC) Director Vijay K. Lathi Sells 34,613 SharesIrhythm Tech (IRTC) Director Vijay K. Lathi Sells 34,613 Shares
www.americanbankingnews.com - September 15 at 4:30 PM
David A. Vort Sells 5,000 Shares of Irhythm Tech (IRTC) StockDavid A. Vort Sells 5,000 Shares of Irhythm Tech (IRTC) Stock
www.americanbankingnews.com - September 13 at 4:34 PM
Insider Selling: Irhythm Tech (IRTC) Director Sells 8,088 Shares of StockInsider Selling: Irhythm Tech (IRTC) Director Sells 8,088 Shares of Stock
www.americanbankingnews.com - September 11 at 4:37 PM
Irhythm Tech (IRTC) Director Raymond W. Scott Sells 4,661 SharesIrhythm Tech (IRTC) Director Raymond W. Scott Sells 4,661 Shares
www.americanbankingnews.com - September 7 at 10:24 PM
iRhythm Technologies to Present at the Morgan Stanley 15th Annual Global Healthcare ConferenceiRhythm Technologies to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
finance.yahoo.com - August 30 at 2:44 AM
Irhythm Tech (IRTC) Director Sells $577,529.70 in StockIrhythm Tech (IRTC) Director Sells $577,529.70 in Stock
www.americanbankingnews.com - August 29 at 10:34 PM
IRHYTHM TECH (NASDAQ:IRTC) Director Raymond W. Scott Sells 52,903 SharesIRHYTHM TECH (NASDAQ:IRTC) Director Raymond W. Scott Sells 52,903 Shares
www.americanbankingnews.com - August 8 at 7:24 PM
Irhythm Tech (IRTC) Posts Quarterly  Earnings Results, Meets ExpectationsIrhythm Tech (IRTC) Posts Quarterly Earnings Results, Meets Expectations
www.americanbankingnews.com - August 3 at 12:44 AM
iRhythm Technologies (IRTC) CEO Kevin King on Q2 2017 Results - Earnings Call TranscriptiRhythm Technologies' (IRTC) CEO Kevin King on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 2 at 11:58 PM
iRhythm Technologies Announces Second Quarter 2017 Financial ResultsiRhythm Technologies Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 2 at 11:58 PM
Irhythm Tech (NASDAQ:IRTC) Sees Large Increase in Short InterestIrhythm Tech (NASDAQ:IRTC) Sees Large Increase in Short Interest
www.americanbankingnews.com - July 29 at 7:10 AM
Irhythm Tech (NASDAQ:IRTC) to Release Earnings on WednesdayIrhythm Tech (NASDAQ:IRTC) to Release Earnings on Wednesday
www.americanbankingnews.com - July 27 at 12:39 PM
 Irhythm Tech (NASDAQ:IRTC) Given Average Recommendation of "Strong Buy" by Brokerages Irhythm Tech (NASDAQ:IRTC) Given Average Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - July 21 at 8:12 AM
iRhythm Technologies to Report Second Quarter 2017 Financial Results on August 2, 2017iRhythm Technologies to Report Second Quarter 2017 Financial Results on August 2, 2017
finance.yahoo.com - July 19 at 10:23 PM
Irhythm Tech (NASDAQ:IRTC) Short Interest UpdateIrhythm Tech (NASDAQ:IRTC) Short Interest Update
www.americanbankingnews.com - July 16 at 7:23 AM
Kevin M. King Sells 110,000 Shares of Irhythm Tech (IRTC) StockKevin M. King Sells 110,000 Shares of Irhythm Tech (IRTC) Stock
www.americanbankingnews.com - July 12 at 5:02 PM
Matthew C. Garrett Sells 25,086 Shares of Irhythm Tech (IRTC) StockMatthew C. Garrett Sells 25,086 Shares of Irhythm Tech (IRTC) Stock
www.americanbankingnews.com - July 12 at 5:02 PM
ETFs with exposure to iRhythm Technologies, Inc. : July 10, 2017ETFs with exposure to iRhythm Technologies, Inc. : July 10, 2017
finance.yahoo.com - July 10 at 7:56 PM
Research Collaboration Demonstrates Use of Deep Learning to Develop Expert Level Comprehensive Cardiac Arrhythmia Detection AlgorithmResearch Collaboration Demonstrates Use of Deep Learning to Develop Expert Level Comprehensive Cardiac Arrhythmia Detection Algorithm
finance.yahoo.com - July 10 at 7:56 PM
iRhythm Technologies (IRTC) CEO Kevin King on Q1 2017 Results - Earnings Call TranscriptiRhythm Technologies' (IRTC) CEO Kevin King on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 6:10 PM
IRhythm Technologies: Potential Short With Attractive Risk/Reward At Current LevelsIRhythm Technologies: Potential Short With Attractive Risk/Reward At Current Levels
seekingalpha.com - April 7 at 10:50 PM
IRHYTHM TECHNOLOGIES, INC. Files SEC form 10-K, Annual ReportIRHYTHM TECHNOLOGIES, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 31 at 6:00 PM
Commercializing Science: Integral To Translation, Not A Dirty WordCommercializing Science: Integral To Translation, Not A Dirty Word
www.forbes.com - March 28 at 11:08 AM
To Translate Medical Science Effectively, Researchers Must Understand CommercializationTo Translate Medical Science Effectively, Researchers Must Understand Commercialization
www.forbes.com - March 28 at 11:08 AM
IRHYTHM TECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal OfficersIRHYTHM TECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - February 22 at 12:34 PM
iRhythm Technologies (IRTC) CEO on Kevin King Q4 2016 Results - Earnings Call TranscriptiRhythm Technologies' (IRTC) CEO on Kevin King Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - February 16 at 8:08 AM
iRhythm Technologies Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial OutlookiRhythm Technologies Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial Outlook
us.rd.yahoo.com - February 15 at 9:08 PM
A tiny patch powering big data is changing the way we monitor heartbeatsA tiny patch powering big data is changing the way we monitor heartbeats
www.cnbc.com - January 30 at 6:42 PM
Medtechs Flock To London As 2016 Sees Biggest IPO EverMedtechs Flock To London As 2016 Sees Biggest IPO Ever
seekingalpha.com - January 20 at 9:08 PM

Social Media

Financials

Chart

Irhythm Tech (NASDAQ IRTC) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.